Clinical Trials Directory

Trials / Completed

CompletedNCT06612489

Efficacy of Biofeedback-Based Serious Game for Pain Alleviation in Middle-Aged and Older Ovarian Cancer Patients: A Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
52 (actual)
Sponsor
Shanghai Jiao Tong University School of Medicine · Academic / Other
Sex
Female
Age
45 Years
Healthy volunteers
Not accepted

Summary

Consistent pain affects most middle-aged and older ovarian cancer patients. Non-pharmacological pain interventions, such as serious games, offer a promising approach to alleviating this pain by providing an effective sense of immersion. However, current games on the pain alleviation lack examination of its efficacy in middle-aged and older population and real-time monitoring of immersion level, particular since immersion level is highly associated with pain alleviation effect and adjustable to challenging level of game difficulty. This study developed a serious game with biofeedback-driven dynamic difficulty. Then examined its feasibility and efficacy through a two-arm, single-blinded randomized controlled trial. A total of 52 participants were recruited and randomized into intervention group and control group to receive biofeedback-based dynamic-difficulty serious game or fix-difficulty serious game for 15 mins each, respectively. The primary outcome was the assessment of the pain level, measured using the Visual Analog Scale. The secondary outcomes included pain-related anxiety, immersion level, and user experience.

Conditions

Interventions

TypeNameDescription
DEVICEbiofeedback based dynamic-difficulty gameA biofeedback based dynamic-difficulty serious game rooted in distraction therapy.
DEVICEfixed difficulty gameA fixed difficulty serious game rooted in distraction therapy.

Timeline

Start date
2023-08-01
Primary completion
2023-09-01
Completion
2024-01-01
First posted
2024-09-25
Last updated
2024-09-25

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06612489. Inclusion in this directory is not an endorsement.